Article
ABCB1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipients.
Biopharmaceutics & drug disposition - 1 Apr 2014
Lee Jun, Huang Hongfeng, Chen Ying, Lu Xiaoyang
Abstract excerpt
Sirolimus, an immunosuppressive drug used to prevent organ rejection after renal transplantation, has a narrow therapeutic index and a large inter-individual variability of pharmacokinetics. The aim of this study was to analyse the dose-normalized trough blood concentrations (C0 /D ratio) of sirolimus in patients with different genotypes and attempt to investigate the possible associations between ABCB1/CYP3A5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
